(Date:11/26/2009)...ommunications announces a highly effective and unc...truggling to make an economic recovery. , ...fears is the type of challenge that could send ail... to Dr. David Benton, business growth expert and a... – The Rfactor Intensive . “Fear is...
(Date:11/25/2009)...wswire/--TheBartleHallConventionCenterwilltemporar...,whenKansasCityhoststhelatestinaseriesofmassivefre...venthasthepotentialtobethebiggestoneyet,becauseitw...kdaysinsteadofoveraweekend,"SheriWood,executivedir...theNationalAssociationofFreeClinics(NAFC). ,, A...
(Date:11/25/2009)...-SentinelleMedicalInc.,aleadingmanufacturerofbreas...suiteofnewleadingedgeclinicalapplicationsonitsAegi...iologicalSocietyofNorthAmerica(RSNA)annualmeetingi...licationsleveragetheuniquehighqualityimagesgenerat...rtmultipleimagingmodalitiesformulti-parametricasse...
(Date:11/25/2009)...re-USNewswire/--TheBlackAIDSInstituterecentlyheldB...hipfor2010. ,, ThenewBoardMembersareahighlydive...,finance,governmenthealthprograms,editorial,andbus...ngeofpersonalbackgroundsincludingbothheterosexuala...andrepresentingmultipleagegroups. ,, (Photo: ht...
(Date:11/25/2009)...r cancer who were treated with cisplatin-based che...neurological side effects and Raynaud-like phenome...y, according to a new study published online Novem...itute . , Marianne Brydy, M.D., of the Departmen...ergen, Norway, and colleagues conducted a cross-se...
Breaking Medicine News(10 mins):Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Black AIDS Institute Announces 2010 Board Election Results 2... a recent study conducted by researchers at Wake F...gues show that cognitive functioning abilities dro...h type 2 diabetes. , The study appears in this mo...rial (ACCORD), found a statistically significant i...
...French . , Montreal, February 11th, 2009 - The ...nt on the nutrients the tumours receive through th...ch Institute of the McGill University Health Centr... stimulate the growth of the blood vessels that fe...
...rld,s first phase one FDA-approved clinical trial ...ase will be conducted by a team of University of ...he first time, patients with advanced heart diseas...ent,s own cardiac tissue. During surgery, a small ...
... Abbott ( NYSE: ABT ),today announced it received...nistration (FDA) for its new, compact hematology i...N Emerald will expand the company,s hematology,pla...ries and clinics continue to seek,greater efficien...
...ges Prevention Through Screenings , ...-- What better time than February, National Cancer...r health is in their own hands? ZocDoc, the servic... month. Now more than ever, New Yorkers are able t...
...ves better predictor than PSA, study says , ...g for changes in the number of circulating tumor c...ostate cancer patients, survival and response to t...ors such as changes in levels of prostate-specific...
Other Medicine News:Health News:Higher blood sugar levels linked to lower brain function in diabetics, study shows 2Health News:Innovative method to starve tumors 2Health News:World's First Cardiac Adult Stem Cell Trial to Take Place in Louisville 2Health News:Abbott Receives FDA Clearance for New CELL-DYN(R) Emerald(TM) Hematology Instrument 2Health News:Abbott Receives FDA Clearance for New CELL-DYN(R) Emerald(TM) Hematology Instrument 3Health News:ZocDoc Joins the Fight Against Cancer 2Health News:Levels of Circulating Tumor Cells Could Predict Prostate Cancer Outcome 2... -, PRINCETON, N.J. and SAN DIEGO, Aug. 18 Tobir...y company committed to the,research and product di...,infectious diseases, today announced the issuance... Trademark Office, covering the use of TBR-652, a,...or the treatment of HIV-1,infection in adults., T...
...Newswire-FirstCall/ -- Pharmaxis,(ASX: PXS; Nasdaq...se 3,clinical trial of Bronchitol for the treatmen...e first efficacy data from the trial is expected t...trial commenced its dosing phase in,April 2007, re...ts in June,2008 and closed today with 325 subjects...
Other Medicine Technology:Bronchitol Phase 3 Cystic Fibrosis Trial Completes Recruitment 2...matology control, offers complete assay values for...ith the Coulter GENS, STKS, MAXM and HmX. This uni...y closed-vial stability and is available in low, n...al is compatible with all cassette systems. Barcod...
Antelys Peek Lumbar Technologies
D-SPECT Cardiac Imaging System
Placemark
Medicine Products: